Trader consensus on the 79% market-implied odds for no new pandemic before 2028 reflects the absence of any emerging pathogen with sustained, high-transmissibility human-to-human spread capable of rapid global escalation. Current CDC and WHO surveillance shows ongoing regional outbreaks—such as Bundibugyo Ebola in the DRC, which has prompted PHEIC declarations but remains geographically limited with thousands of cases—and sporadic reports of chikungunya, Zika, and dengue without evidence of pandemic potential. Post-COVID improvements in genomic sequencing, international reporting, and early containment protocols further lower undetected spillover risks. While influenza strains and zoonotic threats warrant monitoring, no model consensus or recent surveillance data indicate conditions for a novel event meeting pandemic thresholds within the short window.